Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Odontology|June 12, 2012
At the crossroads: EGFR and PTHrP signaling in cancer-mediated diseases of boneJohn Foley, Nicole Nickerson, David J Riese, et al.Human Molecular Genetics|August 25, 2009
Lowe syndrome patient fibroblasts display Ocrl1-specific cell migration defects that cannot be rescued by the homologous Inpp5b phosphataseBrian G Coon, Debarati Mukherjee, Claudia B Hanna, et al.Proceedings of the National Academy of Sciences of the United States of America|August 20, 2008
Modeling oncogene addiction using RNA interferenceS Michael Rothenberg, Jeffrey A Engelman, Sheila Le, et al.Cellular Signalling|October 28, 2008
Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loopNicole E Willmarth, Andrea Baillo, Michele L Dziubinski, et al.Molecular Cancer Research : MCR|October 15, 2009
Reconstitution of amphiregulin-epidermal growth factor receptor signaling in lung squamous cell carcinomas activates PTHrP gene expression and contributes to cancer-mediated diseases of the boneJennifer L Gilmore, Ryan M Gonterman, Keshav Menon, et al.Genes & Cancer|March 7, 2012
ErbB2 Is Necessary for ErbB4 Ligands to Stimulate Oncogenic Activities in Models of Human Breast CancerChristopher P Mill, Michael D Zordan, S Michael Rothenberg, et al.Breast Cancer Research and Treatment|September 21, 2007
Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cellsJennifer L Gilmore, Jeffrey A Scott, Zhor Bouizar, et al.Journal of Veterinary Science|August 13, 2016
Estrogen receptor-α, progesterone receptor, and c-<i>erb</i>B/HER-family receptor mRNA detection and phenotype analysis in spontaneous canine models of breast cancerFarruk M Lutful Kabir, Patricia DeInnocentes, Payal Agarwal, et al.Biochemical and Biophysical Research Communications|October 20, 2007
Inter-conversion of neuregulin2 full and partial agonists for ErbB4Kristy J Wilson, Christopher P Mill, Elizabeth M Cameron, et al.The Biochemical Journal|January 6, 2012
The Q43L mutant of neuregulin 2β is a pan-ErbB receptor antagonistKristy J Wilson, Christopher P Mill, Richard M Gallo, et al.Pageof 5